BioNTech is a biotechnology company based in Germany that focuses on developing and manufacturing personalized immunotherapies for cancer and other serious diseases. Founded in 2008, the company gained global recognition for its involvement in the rapid development of an mRNA-based vaccine for COVID-19 in collaboration with Pfizer. BioNTech’s innovative approach utilizes messenger RNA (mRNA) technology to instruct cells to produce proteins that can elicit an immune response against diseases. This platform not only targets infectious diseases but also aims at creating treatments for various types of cancer and other medical conditions.
BioNTech is shifting focus from COVID-19 vaccines to cancer therapy innovation using mRNA technology. The company faces financial challenges with a decline in earnings and revenue, indicating a tough transition…